サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：循環器系薬剤の世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測
市場調査レポート
商品コード
1175439

循環器系薬剤の世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測

Global Cardiovascular Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日: | 発行: Value Market Research | ページ情報: 英文 203 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
循環器系薬剤の世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測
出版日: 2022年12月01日
発行: Value Market Research
ページ情報: 英文 203 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Value Market Research社は、世界の循環器系薬剤市場を深く調査し、今後数年間の業界の大きな成長を予見しています。循環器系薬剤の世界市場レポートでは、完全な産業分析、市場規模、市場シェア、成長動向、2023年から2028年までの予測などを提供します。本レポートは、詳細な市場イントロダクションと、レポートの主な成長数値にハイライトを当てたエグゼクティブサマリーから始まります。続く章では、市場のバリューチェーン、ポーターのファイブフォースモデル、市場の魅力度分析について論じています。また、COVID-19の影響分析に関する独自の章を設け、市場がパンデミックにどのように対応してきたかを理解していきます。

本レポートの市場力学のセクションでは、現在の市場の促進要因・抑制要因、課題・リスク、今後の機会について詳しく説明しています。このセクションは、企業の戦略担当者や新製品開発部門にとって非常に有益なものとなるでしょう。世界の循環器系薬剤市場の調査では、市場をセグメント化し、収益および/または売上高で市場規模を提供します。このデータは地域別、後に国別に細分化されています。データは、世界中の詳細な一次インタビューや業界の専門家を通じて収集されています。詳細な調査手法は、サンプルレポートでご覧いただけます。これらの市場推定は、この循環器系薬剤市場に影響を与える現在の市場力学とともに、最新の社会的、政治的、経済的変化にも影響されます。

循環器系薬剤市場レポートの次のセクションでは、市場競争力を調査し、いくつかの主要な市場プレーヤー/メーカーのプロファイルを作成します。これらのセクションは、競合他社の製品ライン、財務、最近の市場開拓、業界におけるトップシェアの所有者を理解するための知識を持っています。

目次

第1章 序文

  • 当レポートの内容
    • 目的
    • 対象読者
    • ユニークセリング・プロポジション（USP）および提供サービス
  • 調査範囲
  • 調査手法
    • 市場調査プロセス
    • 市場調査手法

第2章 エグゼクティブサマリー

  • 循環器系薬剤薬市場のハイライト
  • 循環器系薬剤の世界市場スナップショット

第3章 循環器系薬剤- 産業分析

  • イントロダクション
  • 循環器系薬剤薬市場の市場促進要因
  • 循環器系薬剤の市場抑制要因
  • 循環器系薬剤薬の市場機会
  • 循環器系薬剤の市場動向
  • 循環器系薬剤市場のポーターのファイブフォース分析
  • 循環器系薬剤の市場魅力度分析
    • 疾患別市場魅力度分析
    • 薬物クラス別市場魅力度分析
    • 流通チャネル別市場魅力度分析
    • 地域別市場魅力度分析

第4章 バリューチェーン分析

  • 循環器系薬剤のバリューチェーン分析
  • 循環器系薬剤の原材料分析
    • 原材料のリスト
    • 循環器系薬剤の原材料メーカーリスト
    • 循環器系薬剤の主要原材料の価格動向
  • 潜在的なバイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • 間接マーケティング
    • マーケティングチャネルの開発動向

第5章 循環器系薬剤薬の世界市場分析：疾患別

  • 疾患別概要
  • 循環器系薬剤の世界市場：疾患別分析
  • 心筋梗塞：地域別市場分析
  • 動脈硬化：地域別市場分析
  • 急性冠症候群：地域別市場分析
  • 心筋梗塞：地域別市場分析
  • 地域別冠動脈疾患の市場分析
  • 地域別末梢動脈疾患の市場分析
  • 地域別にみた高脂血症の市場分析
  • 地域別高血圧症の市場分析
  • 地域別にみた心不全疾患の市場分析
  • 地域別血栓症の市場分析
  • 地域別その他市場分析

第6章 循環器系薬剤薬の世界市場分析：薬物クラス別

  • 薬物クラス別概要
  • 循環器系薬剤の世界市場分析：薬物クラス別概要
  • 抗高脂血症薬：地域別市場分析
  • 抗線溶薬：地域別市場分析
  • 抗高血圧薬：地域別市場分析
  • 抗不整脈薬：地域別市場分析
  • 抗凝固剤：地域別市場分析
  • 地域別その他市場分析

第7章 循環器系薬剤薬の世界市場分析：流通チャネル別

  • 販売チャネル別の概要
  • 循環器系薬剤の世界市場分析：流通チャネル別概要
  • 病院内薬局：地域別市場分析
  • 小売薬局：地域別市場分析
  • オンライン薬局：地域別市場分析

第8章 循環器系薬剤の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米
    • 概要
    • 北米の循環器系薬剤薬国別市場予測
    • 米国
    • その他北米地域
  • 欧州
    • 概要
    • 欧州の循環器系薬剤市場予測：市場セグメント別
    • 欧州の循環器系薬剤の国別市場推計
    • 英国
    • フランス
    • ドイツ
    • その他の欧州地域
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の循環器系薬剤市場予測：市場セグメント別
    • アジア太平洋地域の循環器系薬剤の国別市場推計
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの循環器系薬剤市場予測：市場セグメント別
    • ラテンアメリカの循環器系薬剤の国別市場推計
    • ブラジル
    • その他のラテンアメリカ地域
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの循環器系薬剤市場予測：市場セグメント別
    • 中東・アフリカの循環器系薬剤の国別市場推計
    • 中東
    • アフリカ

第9章 循環器系薬剤企業の競合情勢

  • 循環器系薬剤の市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Pfizer, Inc.
    • 企業概要
    • 製品紹介
    • 最近の開発状況
  • AstraZeneca plc
    • 会社概要
    • 製品紹介
    • 最近の開発状況
  • Merck & Co.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Sanofi S.A.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Novartis AG
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Daiichi Sankyo Company Limited
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Takeda Pharmaceutical Company Limited
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Bayer AG
    • 会社概要
    • 製品情報
    • 最新情報

企業プロファイルにおいて、財務内容や最近の開発状況は、入手可能な情報に基づくものであり、非公開会社の場合は掲載されていない可能性があります。

図表

LIST OF TABLES

  • Global Cardiovascular Drugs Market Snapshot
  • Drivers of The Global Cardiovascular Drugs Market Impact Analysis
  • Restraints of The Global Cardiovascular Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Cardiac Arrhythmias by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Arteriosclerosis by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Acute Coronary Syndrome by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Myocardial Infarction by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Coronary Artery Disease by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Peripheral Artery Disease by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Hyperlipidaemia by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Hypertension by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Cardiac Failure Diseases by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Thrombosis by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Others by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis by Drug Class (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Hyperlipidemics by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Fibrinolytic by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Hypertensive by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Arrhythmic by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Coagulants by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Others by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis by Distribution Channel (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Cardiovascular Drugs Market by Geography (USD MN)
  • North America Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • North America Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • North America Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • North America Cardiovascular Drugs Market Estimate by Country (USD MN)
  • United State Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • United State Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • United State Cardiovascular Drugs Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Rest of North America Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Rest of North America Cardiovascular Drugs Market Estimate by Distribution Channel(USD MN)
  • Europe Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Europe Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Europe Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • United Kingdom Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • United Kingdom Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • France Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • France Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • France Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Germany Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Germany Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Germany Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Rest of Europe Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Rest of Europe Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Asia Pacific Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Asia Pacific Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Cardiovascular Drugs Market Estimate by Country (USD MN)
  • China Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • China Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • China Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Japan Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Japan Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Japan Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • India Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • India Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • India Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Rest of Asia Pacific Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Rest of Asia Pacific Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Latin America Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Latin America Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Latin America Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Latin America Cardiovascular Drugs Market Estimate by Country (USD MN)
  • Brazil Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Brazil Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Brazil Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Rest of Latin America Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Rest of Latin America Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Middle East & Africa Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Middle East & Africa Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Cardiovascular Drugs Market Estimate by Country (USD MN)
  • Middle East Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Middle East Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Middle East Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Africa Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Africa Cardiovascular Drugs Market Estimate by Drug Class (USD MN)
  • Africa Cardiovascular Drugs Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Cardiovascular Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Cardiovascular Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Disease
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Cardiovascular Drugs Market Analysis by Disease (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Cardiac Arrhythmias by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Arteriosclerosis by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Acute Coronary Syndrome by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Myocardial Infarction by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Coronary Artery Disease by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Peripheral Artery Disease by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Hyperlipidaemia by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Hypertension by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Cardiac Failure Diseases by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Thrombosis by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Others by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis by Drug Class (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Hyperlipidemics by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Fibrinolytic by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Hypertensive by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Arrhythmic by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Anti-Coagulants by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Others by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis by Distribution Channel (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Cardiovascular Drugs Market Analysis in Online Pharmacies by Geography (USD MN)
  • Latin America Cardiovascular Drugs Market by Revenue
  • Middle East & Africa Cardiovascular Drugs Market by Revenue
  • Recent Development in Cardiovascular Drugs Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11212079

Value Market Research deeply researched the Global Cardiovascular Drugs Market to foresee a significant growth in the industry over the upcoming years. The global cardiovascular drugs market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cardiovascular drugs market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cardiovascular drugs market.

The next sections of the cardiovascular drugs market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

  • North America: United States, Canada, and Mexico
  • Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
  • Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC
  • Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America
  • Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Disease

  • Cardiac Arrhythmias
  • Arteriosclerosis
  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Coronary Artery Disease
  • Peripheral Artery Disease
  • Hyperlipidaemia
  • Hypertension
  • Cardiac Failure Diseases
  • Thrombosis
  • Others

By Drug Class

  • Anti-Hyperlipidemics
  • Anti-Fibrinolytic
  • Anti-Hypertensive
  • Anti-Arrhythmic
  • Anti-Coagulants
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Cardiovascular Drugs Market
  • 2.2. Global Cardiovascular Drugs Market Snapshot

3 . CARDIOVASCULAR DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Cardiovascular Drugs Market
  • 3.3. Market Restraints of Cardiovascular Drugs Market
  • 3.4. Opportunities of Cardiovascular Drugs Market
  • 3.5. Trends of Cardiovascular Drugs Market
  • 3.6. Porter's Five Force Analysis of Cardiovascular Drugs Market
  • 3.7. Cardiovascular Drugs Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Disease
    • 3.7.2 Market Attractive Analysis by Drug Class
    • 3.7.3 Market Attractive Analysis by Distribution Channel
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Cardiovascular Drugs Value Chain Analysis
  • 4.2. Cardiovascular Drugs Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Cardiovascular Drugs Raw Material Manufactures List
    • 4.2.3. Price Trend of Cardiovascular Drugs Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CARDIOVASCULAR DRUGS MARKET ANALYSIS BY DISEASE

  • 5.1 Overview by Disease
  • 5.2 Global Cardiovascular Drugs Market Analysis by Disease
  • 5.3 Market Analysis of Cardiac Arrhythmias by Regions
  • 5.4 Market Analysis of Arteriosclerosis by Regions
  • 5.5 Market Analysis of Acute Coronary Syndrome by Regions
  • 5.6 Market Analysis of Myocardial Infarction by Regions
  • 5.7 Market Analysis of Coronary Artery Disease by Regions
  • 5.8 Market Analysis of Peripheral Artery Disease by Regions
  • 5.9 Market Analysis of Hyperlipidaemia by Regions
  • 5.10. Market Analysis of Hypertension by Regions
  • 5.11 Market Analysis of Cardiac Failure Diseases by Regions
  • 5.12 Market Analysis of Thrombosis by Regions
  • 5.13 Market Analysis of Others by Regions

6 . GLOBAL CARDIOVASCULAR DRUGS MARKET ANALYSIS BY DRUG CLASS

  • 6.1 Overview by Drug Class
  • 6.2 Global Cardiovascular Drugs Market Analysis by Drug Class
  • 6.3 Market Analysis of Anti-Hyperlipidemics by Regions
  • 6.4 Market Analysis of Anti-Fibrinolytic by Regions
  • 6.5 Market Analysis of Anti-Hypertensive by Regions
  • 6.6 Market Analysis of Anti-Arrhythmic by Regions
  • 6.7 Market Analysis of Anti-Coagulants by Regions
  • 6.8 Market Analysis of Others by Regions

7 . GLOBAL CARDIOVASCULAR DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Global Cardiovascular Drugs Market Analysis by Distribution Channel
  • 7.3 Market Analysis of Hospital Pharmacies by Regions
  • 7.4 Market Analysis of Retail Pharmacies by Regions
  • 7.5 Market Analysis of Online Pharmacies by Regions

8 . GLOBAL CARDIOVASCULAR DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Cardiovascular Drugs Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Cardiovascular Drugs Market Estimate by Market Segment
    • 8.4.3. Europe Cardiovascular Drugs Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Cardiovascular Drugs Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Cardiovascular Drugs Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Cardiovascular Drugs Market Estimate by Market Segment
    • 8.6.3. Latin America Cardiovascular Drugs Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Cardiovascular Drugs Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Cardiovascular Drugs Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CARDIOVASCULAR DRUGS COMPANIES

  • 9.1. Cardiovascular Drugs Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CARDIOVASCULAR DRUGS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. AstraZeneca plc
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Merck & Co.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Sanofi S.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Daiichi Sankyo Company Limited
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Takeda Pharmaceutical Company Limited
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Bayer AG
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments

Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies